Immudex

Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex is the sole proprietor of DNA barcoded MHC multimer technology. The dCODE Dextramer® technology is an advanced development of Immudex proprietary MHC Dextramer® reagents, which are superior for the detection of antigen-specific T cells. The dCODE® technology enables massive multiplexing of disease-specific T-cell detection overcoming the limitations of earlier technologies. Find out more at www.immudex.com.

Articles by Immudex

Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers

by Immudex

Greatly expands flexibility while ensuring reliable sensitivity in exploring diversity of cellular immune responses

Get a better understanding of cellular immunity

Immudex Launches dCODE Dextramer® (RiO), a New Reagent Compatible with BD Rhapsody™ Single Cell Analysis System

by Immudex

These DNA barcoded MHC Dextramer® reagents are designed to be compatible with the BD Rhapsody™ system to be used for multiplexing